TTT

THERACRYF PLC ORD GBP0.0025

No trades
See on Supercharts

TCF fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

TheraCryf Plc is a clinical stage drug development company, which engages in the development of pharmaceutical products and focus on cancer and neurological disease. Its pipeline includes SFX-01: Breast cancer, SFX-01: Subarachnoid Haemorrhage, and Other Programmes. The company was founded by Stephen Franklin in 2007 and is headquartered in Nether Alderley, CH.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

TCF does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company